US State Peptide Laws & Regulations
Peptide regulations in the United States are primarily governed by federal law (FDA), but individual states may have additional requirements through their Boards of Pharmacy, health departments, or specific legislation.
Note: Most peptide regulation occurs at the federal level through the FDA. State variations primarily affect pharmacy compounding, dispensing requirements, and enforcement priorities. Always verify current regulations with state authorities.
State-by-State Overview
| State | Status | Summary |
|---|---|---|
| Alabama | Restricted | Peptides are restricted in Alabama through professional-licensure enforcement rather than a criminal statute naming peptides directly. Alabama has no statute... |
| Alaska | Gray Area | Peptides occupy a legal gray area in Alaska because the state has not enacted any statute, administrative regulation, or Board of Pharmacy rule that singles... |
| Arizona | Gray Area | Arizona has no statute, administrative code section, or Board of Pharmacy rule that names 'peptides' or 'research chemicals' as their own legal category; the... |
| Arkansas | Gray Area | Peptides are in a legal gray zone in Arkansas because no Arkansas statute, administrative code section, or Arkansas State Board of Pharmacy rule was identified... |
| California | Gray Area | Peptides are not independently legal or illegal in California; the state has no statute that names "peptides" or "research chemicals" as their own legal... |
| Colorado | Gray Area | Colorado has no statute, administrative code section, or Board of Pharmacy rule that names 'peptides' or 'research chemicals' as their own legal category; the... |
| Connecticut | Gray Area | Peptides occupy a legal gray zone in Connecticut because the state legislature and the Connecticut Board of Pharmacy have not enacted any statute, regulation,... |
| Delaware | Gray Area | Delaware has no peptide-specific, research-chemical-specific, or RUO-specific statute or Board of Pharmacy rule; peptide legality in Delaware is instead... |
| Florida | Gray Area | Peptides in Florida are legal only through the prescription-and-licensed-pharmacy pathway, and are not lawful for consumers to buy as unapproved "research... |
| Georgia | Gray Area | Peptides are not legal for unrestricted human use in Georgia when sold as unapproved 'research chemicals'; Georgia has no peptide-specific statute, so the... |
| Hawaii | Gray Area | Hawaii has no law, administrative rule, or Board of Pharmacy bulletin that names peptides, "research chemicals," or research-use-only compounds as a distinct... |
| Idaho | Gray Area | Peptides are not specifically addressed by any Idaho statute or Board of Pharmacy rule naming 'peptides' or 'research chemicals' as a distinct legal category,... |
| Illinois | Gray Area | Peptides are legal in Illinois only through the FDA-approved prescription pathway, and there is no Illinois statute, administrative code section, or Board of... |
| Indiana | Gray Area | Indiana has no peptide-specific or 'research chemical'-specific statute; peptides fall under the general framework that governs any unapproved drug sold or... |
| Iowa | Gray Area | Peptides in Iowa fall into a legal gray area because no Iowa statute or Iowa Administrative Code provision specifically names peptides, "research chemicals,"... |
| Kansas | Gray Area | Kansas has no peptide-specific statute or Board of Pharmacy regulation that separately names 'peptides' or 'research chemicals' as a distinct legal category,... |
| Kentucky | Gray Area | Peptides are not addressed by any Kentucky-specific statute, so the state's legal treatment of them defaults to general federal drug law and Kentucky Board of... |
| Louisiana | Restricted | Peptides are restricted in Louisiana rather than freely legal or flatly illegal: since Act 374 (2026 SB 253) took effect on August 1, 2026, state law (R.S.... |
| Maine | Gray Area | Peptides are in a legal gray zone in Maine because no Maine statute, administrative rule, or Board of Pharmacy chapter names peptides, 'research chemicals,' or... |
| Maryland | Gray Area | Maryland has no statute, regulation, or Board of Pharmacy rule that names "peptides" or "research chemicals" as their own legal category; the state instead... |
| Massachusetts | Gray Area | Peptides have no Massachusetts-specific legal category: there is no state statute, administrative code (247 CMR), or Board of Registration in Pharmacy rule... |
| Michigan | Gray Area | Peptides in Michigan are legal only as FDA-approved prescription medicines or properly compounded products from a licensed pharmacy; unapproved 'research... |
| Minnesota | Restricted | Peptides are restricted in Minnesota, though not through any peptide-specific statute; instead, Minnesota adopts the federal Drug Quality and Security Act's... |
| Mississippi | Gray Area | Peptides occupy a legal gray zone in Mississippi rather than being clearly legal or illegal as a class. Mississippi has no statute or Board of Pharmacy... |
| Missouri | Gray Area | Peptides are in a legal gray area in Missouri because the state has no statute, administrative rule, or Board of Pharmacy regulation that names 'peptides' or... |
| Montana | Gray Area | Peptides in Montana are governed by the same federal/general-pharmacy framework used elsewhere in the US, not by any Montana-specific peptide law. Montana's... |
| Nebraska | Gray Area | Nebraska has no state-specific statute, administrative code provision, or Board of Pharmacy rule that names 'peptides,' 'research chemicals,' or... |
| Nevada | Gray Area | Peptides have no Nevada-specific statute or regulation; the state has not enacted any law naming peptides or research chemicals as a distinct legal category.... |
| New Hampshire | Gray Area | New Hampshire has no statute, administrative rule, or Board of Pharmacy bulletin that names peptides, 'research chemicals,' or research-use-only compounds as a... |
| New Jersey | Gray Area | Peptides are not specifically banned or legalized under any New Jersey statute or Board of Pharmacy rule, so New Jersey's treatment of peptides like BPC-157,... |
| New Mexico | Gray Area | New Mexico has no peptide-specific law; the state's legal treatment of peptides such as BPC-157, TB-500, semaglutide/tirzepatide, and HGH is governed entirely... |
| New York | Gray Area | Peptides in New York occupy a legal gray area because no New York statute, administrative code, or Board of Pharmacy rule names 'peptides' or 'research... |
| North Carolina | Gray Area | North Carolina has no state statute, administrative code section, or Board of Pharmacy rule that names peptides or "research chemicals" as a distinct legal... |
| North Dakota | Gray Area | North Dakota has not enacted any law or administrative rule that names peptides, 'research chemicals,' or research-use-only compounds as a distinct category,... |
| Ohio | Gray Area | Ohio has no peptide-specific statute, administrative code section, or Board of Pharmacy rule that names 'peptides' or 'research chemicals' as a distinct legal... |
| Oklahoma | Gray Area | Peptides are legal in Oklahoma only when handled through the ordinary prescription-drug and pharmacy-compounding framework, because Oklahoma has not enacted... |
| Oregon | Gray Area | Peptides are legal in Oregon only when they are FDA-approved prescription drugs (such as branded semaglutide/tirzepatide or prescription human growth hormone)... |
| Pennsylvania | Gray Area | Pennsylvania has no peptide-specific, research-chemical-specific, or research-use-only statute; the state simply relies on its general Pharmacy Act and Board... |
| Rhode Island | Gray Area | Peptides are in a legal gray zone in Rhode Island: no state statute or Board of Pharmacy regulation creates a distinct 'peptide' or 'research chemical'... |
| South Carolina | Gray Area | South Carolina has no state statute, administrative regulation, or Board of Pharmacy rule that names peptides or 'research chemicals' as a distinct legal... |
| South Dakota | Gray Area | South Dakota has no peptide-specific or "research chemical"-specific statute or Board of Pharmacy rule, so the legal status of any given peptide in South... |
| Tennessee | Gray Area | Peptides do not have a dedicated Tennessee statute; Tennessee has no law that names 'peptides' or 'research chemicals' as a distinct legal category. Instead,... |
| Texas | Gray Area | Peptides are legal in Texas only when they follow the same federal framework used in every state: FDA drug approval, or lawful compounding under Sections... |
| Utah | Gray Area | Utah has no statute, administrative rule, or Board of Pharmacy regulation that names peptides, "research chemicals," or research-use-only compounds as a... |
| Vermont | Gray Area | Peptides occupy a legal gray zone in Vermont because the state has no statute or Board of Pharmacy rule that names peptides, research chemicals, or... |
| Virginia | Gray Area | Virginia has no statute or Board of Pharmacy regulation that names "peptides," "research chemicals," or research-use-only compounds as a distinct legal... |
| Washington | Gray Area | Washington State has no statute or administrative code that names 'peptides' or 'research chemicals' as their own legal category; instead, peptide legality in... |
| West Virginia | Gray Area | West Virginia has no peptide-specific or 'research chemical' statute; state law simply layers the West Virginia Board of Pharmacy's compounding and licensing... |
| Wisconsin | Gray Area | Wisconsin has no law, administrative code section, or Board of Pharmacy rule that names 'peptides' or 'research chemicals' as a distinct legal category.... |
| Wyoming | Gray Area | Peptides are not addressed by any Wyoming-specific statute, administrative code, or Board of Pharmacy rule; Wyoming has no law naming 'peptides' or 'research... |
Understanding State vs Federal Regulation
Federal Authority (FDA)
The FDA has primary authority over drug regulation, including peptides. Key federal regulations include:
- Drug approval requirements under the FD&C Act
- Compounding pharmacy oversight (503A and 503B)
- Import/export controls
- Labeling and marketing requirements
State Authority
States primarily regulate through:
- Boards of Pharmacy: Licensing, compounding standards, dispensing rules
- Health Departments: Public health oversight, clinic regulations
- Attorney General: Consumer protection enforcement
- Legislature: State-specific controlled substance schedules
Key Differences by State
State variations typically affect:
- Compounding pharmacy requirements and inspections
- Telemedicine and telehealth prescribing rules
- Enforcement priorities and resources
- State-scheduled controlled substances (beyond federal DEA schedules)